Dana-Farber Cancer Institute Sales Associate Salaries in Lawrence, MA
The average Dana-Farber Cancer Institute Sales Associate in Lawrence, MA earns an estimated $103,842 annually, which includes an estimated base salary of $65,842 with a $38,000 bonus. Dana-Farber Cancer Institute's Sales Associate compensation is $45,990 more than the US average for a Sales Associate. Sales Associate salaries at Dana-Farber Cancer Institute in Lawrence, MA can range from $74,000 - $110,000.
In Lawrence, MA, The Sales Department at Dana-Farber Cancer Institute earns $160 more on average than the Design Department. Comparably data has a total of 1 salary record from Dana-Farber Cancer Institute Sales Associates.
Last updated 8 months ago.
- $65,842
- avg. base
- $38,000
- avg. bonus
Sales Associate Salaries at Dana-Farber Cancer Institute
In Lawrence, MA, Sales Associates earn $12,915 more than Sales Associates, and $34,288 less than Sales Reps.
Compensation at Dana-Farber Cancer Institute by Department
In Lawrence, MA, The Sales Department averages $160 more than the Design Department, and $9,106 less than the Operations Department
Recent Sales Associate Salaries at Dana-Farber Cancer Institute
Sales Associate Compensation by Gender (All Companies)
The average female Sales Associate at companies similar size to Dana-Farber Cancer Institute reported making $71,067, while the average male Sales Associate at similar sized companies reported making $75,485.
Sales Associate Compensation by Ethnicity (All Companies)
The average Caucasian Sales Associate at companies similar size to Dana-Farber Cancer Institute reported making $67,913, while the average Native American Sales Associate at similar sized companies reported making $35,000.
How Sales Associates at Dana-Farber Cancer Institute Rate Their Compensation
The majority of Sales Associates at Dana-Farber Cancer Institute believe they're compensated fairly. The vast majority (78%) of Sales Associates at Dana-Farber Cancer Institute are satisfied with their benefits. See more compensation ratings at Dana-Farber Cancer Institute
